참고문헌
- Akhavan A, Binesh F, Heidari S (2014). Survival of brain metastatic patients in Yazd, Iran. Asian Pac J Cancer Prev, 15, 3571-4. https://doi.org/10.7314/APJCP.2014.15.8.3571
- Brown PD, Pugh S, Laack NN, et al (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol, 15, 1429-37. https://doi.org/10.1093/neuonc/not114
- Chindaprasirt J, Sookprasert A, Sawanyawisuth K, Limpawattana P, Tiamkao S (2012). Brain metastases from cholangiocarcinoma: a first case series in Thailand. Asian Pac J Cancer Prev, 13, 1995-7. https://doi.org/10.7314/APJCP.2012.13.5.1995
- DeAngelis LM, Delattre JY, Posner JB (1989). Radiationinduced dementia in patients cured of brain metastases. Neurology, 39, 789-96. https://doi.org/10.1212/WNL.39.6.789
- Demircioglu F, Demirci U, Akmansu M (2013). Lymph node ratio assessment of brain metastasis in early breast cancer cases. Asian Pac J Cancer Prev, 14, 1665-7. https://doi.org/10.7314/APJCP.2013.14.3.1665
- Duan L, Zeng R, Yang KH, et al (2014). Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastases: a meta-analysis. Asian Pac J Cancer Prev, 15, 911-5. https://doi.org/10.7314/APJCP.2014.15.2.911
- Dziggel L, Segedin B, Podvrsnik NH, et al (2013). Validation of a survival score for patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol, 189, 364-6. https://doi.org/10.1007/s00066-013-0308-3
- Erten C, Demir L, Somali I, et al (2013). Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? Asian Pac J Cancer Prev, 14, 3711-7. https://doi.org/10.7314/APJCP.2013.14.6.3711
- Hyun MK, Hwang JS, Kim JH, et al (2013). Survival outcomes after whole brain radiation therapy and/or stereotactic radiosurgery for cancer patients with metastatic brain tumors in Korea: a systematic review. Asian Pac J Cancer Prev, 14, 7401-7. https://doi.org/10.7314/APJCP.2013.14.12.7401
- Inamoto T, Azuma H, Nonomura N, et al (2014). Favorable outcome in elderly Asian patients with metastatic renal cell carcinoma treated with everolimus: the Osaka urologic oncology group. Asian Pac J Cancer Prev, 15, 1811-5. https://doi.org/10.7314/APJCP.2014.15.4.1811
- Liu WJ, Zeng XT, Qin HF, et al (2012). Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: a meta-analysis of 19 randomized controlled trials. Asian Pac J Cancer Prev, 13, 3253-8. https://doi.org/10.7314/APJCP.2012.13.7.3253
- Lorenzoni J, Devriendt D, Massager N, et al (2004). Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys, 60, 218-24. https://doi.org/10.1016/j.ijrobp.2004.02.017
- Mutlu H, Buyukcelik A, Erden A, et al (2013). Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival. Asian Pac J Cancer Prev, 14, 3743-6. https://doi.org/10.7314/APJCP.2013.14.6.3743
- Rades D, Panzner A, Dziggel L, et al (2012). Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer, 118, 3852-9. https://doi.org/10.1002/cncr.26680
- Rades D, Dziggel L, Nagy V, et al (2013). A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone. Radiother Oncol, 108, 123-7. https://doi.org/10.1016/j.radonc.2013.06.009
- Sun DS, Hu LK, Cai Y, et al (2014). A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 1233-9. https://doi.org/10.7314/APJCP.2014.15.3.1233
- Vuong DA, Rades D, Le AN, Busse R (2012). The costeffectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families. World Neurosurg, 77, 321-8. https://doi.org/10.1016/j.wneu.2011.05.050
- Vuong DA, Rades D, van Eck AT, Horstmann GA, Busse R (2013). Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection. Clin Neurol Neurosurg, 115, 276-84. https://doi.org/10.1016/j.clineuro.2012.05.005
- Weltman E, Salvajoli JV, Brandt RA, et al (2000). Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys, 46, 1155-61. https://doi.org/10.1016/S0360-3016(99)00549-0
- Yamamoto M, Sato Y, Serizawa T, et al (2012). Subclassification of recursive partitioning analysis class II patients with brain metastases treated radiosurgically. Int J Radiat Oncol Biol Phys, 83, 1399-1405. https://doi.org/10.1016/j.ijrobp.2011.10.018
- Zeng YD, Zhang L, Liao H, et al (2012). Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study. Asian Pac J Cancer Prev, 13, 909-14. https://doi.org/10.7314/APJCP.2012.13.3.909
- Zhang JH, Wang MS, Pan HH, et al (2012). Correlation of CT perfusion images with VEGF expression in solitary brain metastases. Asian Pac J Cancer Prev, 13, 1575-8. https://doi.org/10.7314/APJCP.2012.13.4.1575